Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial

Angiotensin-converting enzyme-2 (ACE2) expression may increase due to upregulation in patients using angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARBs). Because renin-angiotensin system blockers increase levels of ACE2, a protein that facilitates coronavirus ent...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopes, Renato D., Macedo, Ariane Vieira Scarlatelli, de Barros e Silva, Pedro Gabriel Melo, Moll-Bernardes, Renata Junqueira, Feldman, Andre, D'Andréa Saba Arruda, Guilherme, de Souza, Andrea Silvestre, de Albuquerque, Denilson Campos, Mazza, Lilian, Santos, Mayara Fraga, Salvador, Natalia Zerbinatti, Gibson, C. Michael, Granger, Christopher B., Alexander, John H., de Souza, Olga Ferreira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219415/
https://www.ncbi.nlm.nih.gov/pubmed/32502882
http://dx.doi.org/10.1016/j.ahj.2020.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219415/
https://www.ncbi.nlm.nih.gov/pubmed/32502882
http://dx.doi.org/10.1016/j.ahj.2020.05.002

Ejemplares similares